Literature DB >> 29695323

Evaluation of mycobacteria-specific gamma interferon and antibody responses before and after a single intradermal skin test in cattle naturally exposed to M. avium subsp. paratuberculosis and experimentally infected with M. bovis.

Virginie Roupie1, Elena Alonso-Velasco2, Sarah Van Der Heyden3, Sébastien Holbert4, Lucille Duytschaever2, Patricia Berthon4, Iris Van Dosselaer3, Willem Van Campe5, Laurent Mostin5, Franck Biet4, Stefan Roels3, Kris Huygen6, David Fretin2.   

Abstract

This study reports on the diagnostic potential of IFN-γ release assays and serology for Mycobacterium bovis in six naturally M. avium subsp. paratuberculosis (Map) exposed bulls of which four were intratracheally infected with a Belgian field strain of M. bovis. Heparinized blood, serum and fecal samples were collected at regular time intervals for mycobacteria-specific IFN-γ release assays, antibody analysis and for Map culture respectively. Single intradermal skin test (SIT) with bovine tuberculin (PPD-B) was performed on day 115 and animals were sacrificed on day 133 after M. bovis infection. Organs were collected and stored for histopathological examination, modified Ziehl-Neelsen staining and bacteriological analysis of M. bovis and Map by culture and RT-PCR. Prior to infection five animals showed positive IFN-γ responses to avian PPD (PPD-A) and four were positive in Map PCR (IS900) on faeces. Three M. bovis infected animals reacted as early as day 14 with sustained higher PPD-B than PPD-A specific IFN-γ responses, whereas the fourth animal (with the strongest PPD-A response prior to infection) showed sustained higher PPD-B specific IFN-γ levels only a day 56 after infection. Two of the infected animals had a sustained positive IFN-γ response to the ESAT-6/CFP-10/TB7.7 (QuantiFERON®-TB Gold) peptide cocktail as early as day 14, among which the animal with the initial high PPD-A response. Later during infection, positive responses were found to ESAT-6 peptides in three infected bulls and to CFP-10 peptides in all four infected bulls. One of the control animals reacted intermittently to the ESAT-6/CFP10/TB7.7 cocktail. Prior to SIT, weak but positive MPB83/MBP70 specific antibody responses were detected in two of the infected bulls. All four M. bovis infected bulls reacted with a positive skin test and showed, as reported by others, increased mycobacteria specific IFN-γ production and increased positive responses in MPB83/MBP70 specific serology after SIT. At autopsy, M. bovis lesions were detected in all four experimentally infected bulls. Our results indicate that in Map exposed cattle, M. bovis diagnosis using IFN-γ assays needs a combination of PPD-B/A and ESAT-6/CFP10 for early and optimal sensitivity and that sensitivity of MPB83/MBP70 serodiagnosis is dramatically increased by prior skin testing. Map exposure did not interfere with the development of SIT in M. bovis infected animals, but resulted in a false positive M. bovis specific IFN-γ and antibody response after SIT in one of the two control animals (which remained negative in skin-test).
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Experimental infection; IFN-γ test; M. bovis; M. paratuberculosis; Serology; Single intradermal skin test

Mesh:

Substances:

Year:  2017        PMID: 29695323     DOI: 10.1016/j.vetimm.2017.12.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Early Detection of Mycobacterium avium subsp. paratuberculosis Infected Cattle: Use of Experimental Johnins and Innovative Interferon-Gamma Test Interpretative Criteria.

Authors:  Sara Corneli; Antonella Di Paolo; Nicoletta Vitale; Martina Torricelli; Linda Petrucci; Carla Sebastiani; Marcella Ciullo; Ludovica Curcio; Massimo Biagetti; Paola Papa; Silva Costarelli; Monica Cagiola; Alessandro Dondo; Piera Mazzone
Journal:  Front Vet Sci       Date:  2021-05-14

2.  Is There a Relationship Between Bovine Tuberculosis (bTB) Herd Breakdown Risk and Mycobacterium avium subsp. paratuberculosis Status? An Investigation in bTB Chronically and Non-chronically Infected Herds.

Authors:  Andrew W Byrne; Jordon Graham; Georgina Milne; Maria Guelbenzu-Gonzalo; Sam Strain
Journal:  Front Vet Sci       Date:  2019-02-14

3.  Study on supplemental test to improve the detection of bovine tuberculosis in individual animals and herds.

Authors:  Paulo Alex Machado Carneiro; Eliomar de Moura Sousa; Rinaldo Batista Viana; Bruno Moura Monteiro; Aline do Socorro Lima Kzam; Damazio Campos de Souza; Anderson Silva Coelho; José Dantas Ribeiro Filho; Ricardo Spacagna Jordao; Maria Regina Madruga Tavares; John B Kaneene
Journal:  BMC Vet Res       Date:  2021-03-31       Impact factor: 2.741

4.  Development and Validation of a Novel ELISA for the Specific Detection of Antibodies against Mycobacterium avium Subspecies paratuberculosis Based on a Chimeric Polyprotein.

Authors:  Roberto Damián Moyano; Magali Andrea Romero; María Alejandra Colombatti Olivieri; María Fiorella Alvarado Pinedo; Gabriel Eduardo Traveria; María Isabel Romano; María Natalia Alonso
Journal:  Vet Med Int       Date:  2021-12-29

5.  Protein Levels of Pro-Inflammatory Cytokines and Chemokines as Biomarkers of Mycobacterium bovis Infection and BCG Vaccination in Cattle.

Authors:  Hamza Khalid; Anouk van Hooij; Timothy K Connelley; Annemieke Geluk; Jayne C Hope
Journal:  Pathogens       Date:  2022-06-29

6.  Diagnostic interaction between bovine tuberculosis (bTB) and Johne's disease in bTB highly prevalent dairy farms of Uruguay.

Authors:  C Picasso-Risso; A Gil; A Nunez; A Suanes; V Macchi; X Salaberry; J Alvarez; A Perez
Journal:  Vet Anim Sci       Date:  2019-02-21

7.  Characteristic profile of antibody responses to PPD, ESAT-6, and CFP-10 of Mycobacterium tuberculosis in pulmonary tuberculosis suspected cases in Surabaya, Indonesia.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih; Yuriko Ozeki; Wayan Tunas Artama; Mamiko Niki; Yoshitaka Tateishi; Manabu Ato; Sohkichi Matsumoto
Journal:  Braz J Infect Dis       Date:  2019-08-14       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.